What is the current price for "Which vaccines will the CDC no longer recommend in 2026?"?

The leading outcome "No" is currently trading at 95.4% probability.

How many markets are available for "Which vaccines will the CDC no longer recommend in 2026?"?

There are 6 markets available for this event on Kalshi.

What is the trading volume for "Which vaccines will the CDC no longer recommend in 2026?"?

Trading volume data is not currently available.

BackKKALSHI

Which vaccines will the CDC no longer recommend in 2026?

Yes21%

Vol$0.00

Markets6

21%

TradeTrade on Kalshi

Event Group

EventKALSHI

Single EventKALSHIPolitics

Which vaccines will the CDC no longer recommend in 2026?

Name: Which vaccines will the CDC no longer recommend in 2026?
Start: 2026-07-10T08:25:20.229Z
End: 2026-08-09T08:25:20.229Z

Part of: Which vaccines will the CDC no longer recommend in 2026?

Before Jan 1, 2027 If the CDC ends its recommendation completely X vaccine before Jan 1, 2027, then the market resolves to Yes. Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Criterion. This market will close and expire early if the event occurs.

YesLeading Yes Probability

21%

VolTotal Volume

$0.00

Markets

Trade on Kalshi

Which vaccines will the CDC no longer recommend in 2026?

Yes

21%

Vol

$0.00

Markets

Trade

Market Price Graph

6 markets tracked

Will the CDC end its recommendation for the COVID-19 vaccine?

kalshi

No data available

All Markets(6)

Market	Price
Will the CDC end its recommendation for the COVID-19 vaccine?	21%
Will the CDC end its recommendation for the Influenza vaccine?	10%
Will the CDC end its recommendation for the Hepatitis B vaccine?	9%
Will the CDC end its recommendation for the Polio vaccine?	5%
Will the CDC end its recommendation for the Rotavirus vaccine?	5%

Markets (6)

Sort

KALSHIHealth

Will the CDC end its recommendation for the COVID-19 vaccine?

If the CDC ends its recommendation completely for the COVID-19 vaccine before Jan 1, 2027, then the market resolves to Yes. Secondary rules: Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Crite

Will the CDC end its recommendation for the Influenza vaccine?

If the CDC ends its recommendation completely for the Influenza vaccine before Jan 1, 2027, then the market resolves to Yes. Secondary rules: Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Crit

Will the CDC end its recommendation for the Hepatitis B vaccine?

If the CDC ends its recommendation completely for the Hepatitis B vaccine before Jan 1, 2027, then the market resolves to Yes. Secondary rules: Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Cr

Will the CDC end its recommendation for the Polio vaccine?

If the CDC ends its recommendation completely for the Polio vaccine before Jan 1, 2027, then the market resolves to Yes. Secondary rules: Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Criterio

Will the CDC end its recommendation for the Rotavirus vaccine?

If the CDC ends its recommendation completely for the Rotavirus vaccine before Jan 1, 2027, then the market resolves to Yes. Secondary rules: Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Crit

Will the CDC end its recommendation for the Dengue vaccine?

If the CDC ends its recommendation completely for the Dengue vaccine before Jan 1, 2027, then the market resolves to Yes. Secondary rules: Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Criteri